Russell Lonser, M.D.
@RussellLonser
Chair, Department of Neurosurgery, @OhioStateMed | Director, @OSUGeneTherapy | Past-Chair, #ABNS | Treasurer, #AAcNS | Past-President, @CNS_Update
Delighted to announce that Daniel Schneider (@DrDanSchneider), M.D., will be joining @NeurosurgeryOSU, August 1, 2025. He completed his #neurosurgery residency and his spinal oncology fellowship at @NorthwellNsurg with @DanielSciubba. He will further expand our spine oncology…


Brian Park, MD (@Brian89594738)
Delighted to announce that Brian Park, M.D., will be joining @NeurosurgeryOSU, July 1, 2025. He completed his #neurosurgery residency at @IowaNeurosurg and his complex spine fellowship at @UMneurosurgery with Michael Wang, M.D. He will further expand our spine treatment,…
Delighted to announce that Brian Park, M.D., will be joining @NeurosurgeryOSU, July 1, 2025. He completed his #neurosurgery residency at @IowaNeurosurg and his complex spine fellowship at @UMneurosurgery with Michael Wang, M.D. He will further expand our spine treatment,…

👀Big thank you to Dr. Andras Komaromy for his fantastic presentation on developing ocular #genetherapy approaches for #glaucoma 🧬 @msuvets @OhioStateEye
Kreatsoulas et al. @NeurosurgeryOSU @RussellLonser developed and validated the MBLS to predict 90-day post-op survival in brain metastasis, offering a practical tool for pre-op risk stratification based on imaging and clinical factors. #JNO Read more:link.springer.com/article/10.100…
Delighted to announce that Amy Gleichman, Ph.D., (@amy_gleichman) has joined @NeurosurgeryOSU and the @OSUGeneTherapy. She completed her Ph.D. at the University of Pennsylvania and post doctoral training at @UCLA. She brings incredible expertise that will further expand our…

Driven by early therapeutic signals, the rapid expansion of gene and cell-based therapies for neurologic disorders is transforming neurosurgical treatment possibilities. A summary statement from #IGNITE meeting attendees, published in @TheJNS, defines current state, future…

I am incredibly proud of our 3 @NeurosurgeryOSU graduating Chiefs (left to right, Jora, Asad and Dan) this year. They are incredible surgeons and people. Their impact on #neurosurgery and beyond will be immense and indelible. @OhioStateMed @OSUWexMed @OSUCCC_James

Extraordinarily proud of the exceptional neurosurgeon that Jora has become during his training.
Great shot of one of our graduating chief residents Dr. Jora Dhaliwal operating with our Chair @RussellLonser.
Honored and excited to be the @MCWNeurosurgery Graduation Speaker. An incredible and historic program with world-class faculty and trainees. Always great to see long time friends and national leaders, Shelly Timmons, @shekarkurpad, and Marjorie Wang.

So proud to be an alumnus of @UofUNeurosurg and to have trained alongside such incredible talent. Thrilled to be named amongst other fellow Utah graduates, co-residents, and former faculty recognized on the Avant-Garde Health Research All-Star List! @AdamArthurMD @MichaelKarsy…
Fantastic first session at the Inaugural #genetherapy Symposium! Russ Lonser, MD gave an overview of the Gene Therapy Institute 🧬 @RussellLonser
So honored to have our chair @RussellLonser give a talk on gene therapy 🧬 this morning at Grand Rounds. Dr. Lonser and @OSUGeneTherapy are world leaders in gene therapy!
I had an incredible time at the 49th Annual Louisiana Neurosurgical Society (#LANS) Meeting. I was truly honored to be part of this meeting with an incredible group of neurosurgeons in a wonderful setting (#NOLA). #VHL #abns @OhioStateMed @NeurosurgeryOSU @OSUWexMed




We are excited and proud to train these future leaders in neurosurgery.
Couldn’t be more excited to announce our 2025 match results! Welcome to Ohio State Neurosurgery Chandler Berke, Jakob Jarmula, Spencer Raub, and Bradley Wilhelmy!
The 2025 Big 10 #Neurosurgery Academic Alliance meeting in Pasadena, California was an incredible opportunity to meet, share scientific ideas and collaborate with #Big10 neurosurgery colleagues and industry partners. This unique opportunity is advancing the field and patient…
